Global /Australia /Healthcare /Drug Manufacturers - Specialty & Generic /PKP

Peak Processing Ltd.

PKP

• ASX: PKP • Delayed

0.0170AUD 0%

0.0120 USD

As of 7 June 2026, Peak Processing Ltd. has a market cap of $14.08M USD, ranking #39368 globally and #1213 in Australia. It ranks #3508 in the Healthcare sector, and #233 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

39368

Country Rank

1213

Sector Rank

3508

Industry Rank

233

Key Stats

Market Cap

$14.08MUSD

19.73M AUD

Enterprise Value

$17.32MUSD

24.59M AUD

Revenue (TTM)

$10.41MUSD

14.59M AUD

EBITDA (TTM)

-$2.79MUSD

-3.96M AUD

Net Income (TTM)

-$8.74MUSD

-12.25M AUD

EBITDA Margin

-27%

Profit Margin

-84%

PS Ratio

1.4

PB Ratio

-6.6

Company Profile

Country (HQ)

Australia

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Barry Katzman open_in_new

Founded

2016

Website

peakprocessing.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	0%	6.3%	-5.6%	-15%	-11%	-23%	-70%	-96%

News

Markets

Exchange	Ticker	Price	Quotes
Australian Securities Exchange (ASX) MIC: XASX PRIMARY	PKP ISIN: AU0000442287 Shares Out.: Shares Outstanding: 1.161B¹ Shares Float: 1.031B² TV: TradingView: ASX: PKP SA: Stock Analysis: ASX: PKP YF: Yahoo Finance: PKP.AX GF: Google Finance: ASX: PKP BA: Barron's: PKP MS: Morningstar: XASX: PKP	0.0170 AUD	TV: TradingView: ASX: PKP SA: Stock Analysis: ASX: PKP YF: Yahoo Finance: PKP.AX GF: Google Finance: ASX: PKP BA: Barron's: PKP MS: Morningstar: XASX: PKP

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Peak Processing Ltd.

Peak Processing Limited, together with its subsidiaries, manufactures, distributes, and sells recreational cannabis products in Canada and the United States. The company offers cannabis products, including beverages, hydrocarbon extracts, oils, vapes, oils, topicals, powders, infused flowers, and edibles. It also provides market insights and analysis, product development, manufacturing, commercialization, distribution, and product rework services. The company sells its products through retail stores. The company was formerly known as Althea Group Holdings Limited and change its name to Peak Processing Limited in November 2025. Peak Processing Limited was founded in 2016 and is based in Melbourne, Australia.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (Australia)

Name	Market Cap (USD) diff.	PE	Country
Neuren Pharmaceuticals Ltd. ASX: NEU	$1.11B 1.55B AUD 8K%	52.7	Australia
Actinogen Medical Ltd. ASX: ACW	$123.03M 172.39M AUD 774%	-	Australia
Clover Corporation Ltd. ASX: CLV	$114.37M 160.26M AUD 712%	18.1	Australia
Vita Life Sciences Ltd. ASX: VLS	$100.03M 140.17M AUD 610%	14.1	Australia
Paradigm Biopharmaceuticals Ltd. ASX: PAR	$56.42M 79.06M AUD 301%	-	Australia
Beroni Group Ltd. OTCMKTS: BNIGF	$49.41M 251%	-	Australia

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 267K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 210K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 113K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 79K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 78K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 65K%	80.6	China

chevron_leftBack